Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 157Unknown 7Recruiting 7Terminated 5Active not recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 10INDUSTRY 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Dermatologic 5

Conditions

Neoplasms 474Carcinoma, Non-Small-Cell Lung 449Breast Neoplasms 331Neoplasm Metastasis 243Colorectal Neoplasms 214Melanoma 213Leukemia, Myeloid, Acute 191Multiple Myeloma 180Recurrence 169Ovarian Neoplasms 169Prostatic Neoplasms 163Lymphoma, Non-Hodgkin 149Lung Neoplasms 134Pancreatic Neoplasms 125Lymphoma 124Carcinoma, Renal Cell 112Leukemia, Lymphocytic, Chronic, B-Cell 111Squamous Cell Carcinoma of Head and Neck 110Stomach Neoplasms 92Carcinoma, Hepatocellular 89Lymphoma, Large B-Cell, Diffuse 88Leukemia 88Triple Negative Breast Neoplasms 86Lymphoma, Follicular 82Head and Neck Neoplasms 79Glioblastoma 75Myelodysplastic Syndromes 70Urinary Bladder Neoplasms 68Small Cell Lung Carcinoma 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 55

Interventions

LEO 43204 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Keratosis, Actinic × Clear all
NCT03115476 2025-03-11

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

LEO Pharma

Phase 3 Terminated
563 enrolled 15 charts
Dermatologic

Carcinoma, Squamous Cell, Keratosis, Actinic

NCT04269395 2023-10-10

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Galderma R&D

Phase 3 Terminated
125 enrolled 8 charts
Dermatologic

Keratosis, Actinic

NCT01806961 2016-08-03

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Spirig Pharma Ltd.

Terminated
16 enrolled 4 charts
Dermatologic

Keratosis, Actinic

NCT01532453 2016-01-08

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Spirig Pharma Ltd.

Phase 3 Terminated
244 enrolled 9 charts
Dermatologic

Carcinoma, Squamous Cell, Keratosis, Actinic

NCT00865878 2011-10-21

ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients

DUSA Pharmaceuticals, Inc.

Phase 2 Terminated
6 enrolled
Dermatologic

Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡